ContractDynavax Technologies Corp • August 4th, 2021 • Pharmaceutical preparations • England and Wales
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.
First Amendment to AgreementTo Agreement • August 4th, 2021 • Dynavax Technologies Corp • Pharmaceutical preparations
This First Amendment to Agreement (“First Amendment”) is entered into as of the date of last signature by and between Coalition for Epidemic Preparedness Innovations, having an address of PO Box 123, Torshov, N-0412 Oslo, Norway (“CEPI”), and Dynavax Technologies Corporation, having an address of 2100 Powell Street, Suite 900, Emeryville, CA 94608, USA (“Dynavax”). Each of CEPI and Dynavax is referred to herein individually as a “Party” and are collectively referred to herein as the “Parties.”
Supply AgreementDynavax Technologies Corp • August 4th, 2021 • Pharmaceutical preparations • England and Wales
AMENDMENT NO. 5 TO TERM LOAN AGREEMENTTerm Loan Agreement • August 4th, 2021 • Dynavax Technologies Corp • Pharmaceutical preparations • New York
THIS AMENDMENT NO. 5 TO TERM LOAN AGREEMENT, dated as of [May 1], 2021 (this “Agreement”), is made among Dynavax Technologies Corporation, a Delaware corporation (the “Borrower”), the Subsidiary Guarantors party hereto, the Lenders party hereto and CRG Servicing LLC, as administrative agent and collateral agent (in such capacities, “Agent”), with respect to the Loan Agreement referred to below.
